Erudio Healtherudio.com
Drug
Petosemtamab trials: what clinicians said in public
An HCP commentary report on 1 clinical trial studying petosemtamab: LiGeR-HN1. It covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source.